Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,585 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06267508Recruiting
HIV testing and treatment for newborns
This study looks at ways to test and treat newborns for HIV early to improve their long-term health. It is for mothers with HIV whose babies are less than 3 days old and who are willing to have their babies tested and followed at home.
BeiraAges 18 years+ - NCT06268457Recruiting
Arterial Chemoembolization for Desmoid Tumors
This trial tests a procedure called arterial chemoembolization (TACE) for people with symptomatic desmoid tumors that are growing and cannot be treated with surgery or cryoablation. The goal is to see if this targeted treatment can control the tumor and relieve symptoms.
Bologna, Emilia-RomagnaAges 18 years+ - NCT06268496Recruiting
Study of a cream for facial dark spots
This trial tests a skincare formula for treating three types of dark spots on the face: melasma, acne marks, and age spots. It aims to see if the product is effective and gentle after 3 months of daily use.
OsascoAges 18 years+ - NCT06268964RecruitingPhase 1/Phase 2
Trimebutine vs probiotics for kids with belly pain
This study compares two treatments—trimebutine and probiotics—to see which works better for children with recurring stomach pain that has no clear medical cause. It aims to find a safe and effective option for kids aged 4 to 18.
ColimaAges 4–18 - NCT06269198Recruiting
Monitoring complications after cancer surgery
This trial tests a smart monitoring system to watch for complications after major cancer surgery. It may help doctors catch problems early so you can recover better.
Copenhagen, Other (Non US)Ages 18 years+ - NCT06270017RecruitingPhase 1/Phase 2
Zebrafish Avatars for Colon Cancer Treatment
This trial uses tiny zebrafish to grow a piece of your tumor and test which treatments might work best for you. It is for patients with colon cancer who are scheduled for surgery to remove their tumor.
Linköping, Östergötland CountyAges 18 years+ - NCT06271590Recruiting
Drug-coated balloon for small heart artery blockages
This trial tests a special balloon coated with a drug (sirolimus) to treat blockages in small heart arteries. If the balloon is successful, it may help keep the artery open without needing a permanent stent.
Gilbert, ArizonaAges 18–80 - NCT06272084Recruiting
Review of plasmapheresis treatments (TPE) using multiFiltratePRO
This study looks back at the medical records of people who had plasmapheresis (TPE) treatment to learn more about how it works. If you had this treatment between 2019 and 2023, researchers may use your data.
Aschaffenburg, BavariaAges 18 years+ - NCT06273046Recruiting
Biofeedback for bowel control problems
This trial tests a non-invasive biofeedback technique to help people regain control of bowel movements. It may be an option for those with frequent stool leakage or difficult constipation, but participants must not have certain other digestive or neurological conditions.
BarcelonaAges 18–75 - NCT06273644Recruiting
Carbohydrate-rich diet for acute intermittent porphyria
This trial tests whether a diet high in carbohydrates can help treat acute intermittent porphyria (AIP), a condition that can cause attacks of pain and other symptoms. If you have AIP, this study wants to see if eating more carbs can prevent or manage attacks.
Bodø, NordlandAges 18 years+ - NCT06275022Recruiting
Using ICG dye to guide treatment of facial birthmarks
This study tests whether a special dye called ICG can help doctors treat a type of facial birthmark called capillary lymphatic malformation (cLM) more effectively. It may help by showing the birthmark more clearly during treatment.
Nanjing, JiangsuAges 4 weeks–16 years - NCT06274320Recruiting
Testing a urea cream before actinic keratosis treatment
This trial tests whether applying a 30% urea cream (Lipikar) before Tolak® treatment helps treat actinic keratoses (rough, scaly spots) on the scalp. It may make the skin more receptive to the treatment.
WuppertalAges 18 years+ - NCT06276465RecruitingPhase 3
Darolutamide with or without radiation for advanced prostate cancer
This trial tests whether adding radiation therapy to the drug darolutamide helps men with a specific type of advanced prostate cancer that has stopped responding to hormone therapy and has spread to a few spots seen on special scans. The study aims to find the best way to control the cancer while keeping side effects manageable.
LorientAges 18 years+ - NCT06277024Recruiting
Combination therapy for advanced HER2-negative stomach cancer
This trial tests a combination of immunotherapy (candenizumab), a targeted therapy (lenvatinib), and chemotherapy (SOX regimen) for advanced HER2-negative stomach or gastroesophageal junction cancer that has not been treated before. The goal is to see if this combination is safe and works better than standard treatments.
Fuzhou, FujianAges 18–75 - NCT06277154RecruitingPhase 2
MASCT-I plus chemo for first-line advanced soft tissue sarcoma
This trial tests a new immune cell therapy (MASCT-I) combined with standard chemotherapy (doxorubicin and ifosfamide) for people with advanced soft tissue sarcoma who have not had prior chemotherapy or targeted therapy. The goal is to see if the combination works better than chemo alone.
GuangzhouAges 18–70 - NCT06277063Recruiting
Nerve-stimulation device for headache in children and young adults
This trial tests if a gentle nerve-stimulating device worn on the neck (called nVNS) can prevent and treat common headaches like migraine, cluster, and tension-type headaches in children and young adults. If you often get headaches and want a drug-free option, this might help.
Guangzhou, GuangdongAges 7–20 - NCT06278207Recruiting
Finerenone in real-world diabetes and kidney disease
This study looks at how the medication finerenone works in everyday medical practice for people with type 2 diabetes and certain stages of chronic kidney disease. It aims to see how safe and effective the treatment is outside of a clinical trial setting.
Multiple Locations, New JerseyAges 18 years+ - NCT06278194Recruiting
Masseter muscle thickness in gasser ganglion radiofrequency treatment
This trial studies how radiofrequency treatment for facial pain affects the thickness of your chewing muscle. It may help improve future treatments.
Istanbul, BaşakşehirAges 40–85 - NCT06278974Recruiting
Comparing myopia treatments for kids: glasses vs ortho-k
This study compares three ways to slow down nearsightedness in children: special glasses (defocus lenses), regular glasses, and orthokeratology contact lenses (worn overnight). It aims to find which works best for kids who have never worn glasses before.
Shenyang, LiaoningAges 7–17 - NCT06278909Recruiting
Nerve stimulation for stubborn anxiety
This study tests a new, non-invasive treatment using mild electrical stimulation on a nerve in your face (trigeminal nerve) to help with anxiety that hasn't improved with other treatments. It aims to see if this approach is safe and helpful for people with generalized anxiety disorder who have not responded to standard medications.
Kingston, OntarioAges 18–65 - NCT06278922Recruiting
A therapy toolkit for Deaf people with alcohol and trauma issues
This study tests a therapy toolkit designed for Deaf or hard-of-hearing people who struggle with alcohol use and have experienced trauma. The therapy is provided in ASL via video sessions, and the goal is to see if it helps reduce drinking and PTSD symptoms.
Worcester, MassachusettsAges 18 years+ - NCT06279026Recruiting
Testing UTAA17 for advanced multiple myeloma
This trial tests a new treatment called UTAA17 that targets a protein on myeloma cells. It may be an option for people whose multiple myeloma has not responded to several prior treatments.
Suzhou, JiangsuAges 18 years+ - NCT06281210Recruiting
Test to skip breast surgery after chemo
This trial checks if a breast biopsy can confirm that chemo has destroyed all cancer cells, so you might avoid surgery altogether. It's for people with aggressive breast cancer types who responded well to chemotherapy.
Candiolo, TurinAges 18 years+ - NCT06281665RecruitingPhase 4
Aspirin after preeclampsia: the TAP trial
This trial tests whether taking low-dose aspirin after giving birth can help people who had preeclampsia. It aims to see if aspirin can lower the risk of future heart problems.
Pittsburgh, PennsylvaniaAges 18–55
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,585 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.